Yun-han Lee

Daegu, Republic of Korea

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 39 publications

Functional Role of COP1 Gene in Hepatocellular Carcinoma Lipid Metabolism and Stemness.

Functional Role of COP1 Gene in Hepatocellular Carcinoma Lipid Metabolism and Stemness.

Journal: Genes to cells : devoted to molecular & cellular mechanisms

Published: March 21, 2025

Ribosomal Protein L9 Maintains Stemness of Colorectal Cancer via an ID-1 Dependent Mechanism.

Ribosomal Protein L9 Maintains Stemness of Colorectal Cancer via an ID-1 Dependent Mechanism.

Journal: Journal of cancer prevention

Published: April 30, 2024

RPL27 contributes to colorectal cancer proliferation and stemness via PLK1 signaling.

RPL27 contributes to colorectal cancer proliferation and stemness via PLK1 signaling.

Journal: International journal of oncology

Published: February 15, 2023

Clinical Characteristics of TZAP (ZBTB48) in Hepatocellular Carcinomas from Tissue, Cell Line, and TCGA.

Clinical Characteristics of TZAP (ZBTB48) in Hepatocellular Carcinomas from Tissue, Cell Line, and TCGA.

Journal: Medicina (Kaunas, Lithuania)

Published: September 18, 2022

Therapeutic targeting of alternative splicing to inhibit hepatocellular carcinoma metastasis.

Therapeutic targeting of alternative splicing to inhibit hepatocellular carcinoma metastasis.

Journal: Translational cancer research

Published: September 13, 2022

Loss of phospholipase Cγ1 suppresses hepatocellular carcinogenesis through blockade of STAT3-mediated cancer development.

Loss of phospholipase Cγ1 suppresses hepatocellular carcinogenesis through blockade of STAT3-mediated cancer development.

Journal: Hepatology communications

Published: February 10, 2022

RPL17 Promotes Colorectal Cancer Proliferation and Stemness through ERK and NEK2/β-catenin Signaling Pathways.

RPL17 Promotes Colorectal Cancer Proliferation and Stemness through ERK and NEK2/β-catenin Signaling Pathways.

Journal: Journal of Cancer

Published: November 25, 2021

Silencing CDCA8 Suppresses Hepatocellular Carcinoma Growth and Stemness via Restoration of ATF3 Tumor Suppressor and Inactivation of AKT/β-Catenin Signaling.

Silencing CDCA8 Suppresses Hepatocellular Carcinoma Growth and Stemness via Restoration of ATF3 Tumor Suppressor and Inactivation of AKT/β-Catenin Signaling.

Journal: Cancers

Published: February 01, 2021

Targeting CALM2 Inhibits Hepatocellular Carcinoma Growth and Metastasis by Suppressing E2F5-mediated Cell Cycle Progression.

Targeting CALM2 Inhibits Hepatocellular Carcinoma Growth and Metastasis by Suppressing E2F5-mediated Cell Cycle Progression.

Journal: Anticancer research

Published: January 14, 2021

Clinicopathological Characteristics of TZAP Expression in Colorectal Cancers.

Clinicopathological Characteristics of TZAP Expression in Colorectal Cancers.

Journal: OncoTargets and therapy

Published: August 10, 2020

Histone deacetylase inhibitor CG200745 ameliorates high-fat diet-induced hypertension via inhibition of angiotensin II production.

Histone deacetylase inhibitor CG200745 ameliorates high-fat diet-induced hypertension via inhibition of angiotensin II production.

Journal: Naunyn-Schmiedeberg's archives of pharmacology

Published: June 25, 2019

Disruption of the Myc-PDE4B regulatory circuitry impairs B-cell lymphoma survival.

Disruption of the Myc-PDE4B regulatory circuitry impairs B-cell lymphoma survival.

Journal: Leukemia

Published: September 16, 2018

Showing 1-12 of 39

Last Updated: 09/26/2026